Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function

Clinical trial NCT00652626 · COMPLETED

Trial details

NCT number: NCT00652626
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

MDS AML Solid Tumors Multiple Myeloma Non-Hodgkin's Lymphoma Hodgkin's Disease

Start date: 2008-11-01
Primary completion: 2012-07-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.